Kidney international
-
Kidney international · Mar 2006
CommentVoluntary reciprocal altruism: a novel strategy to encourage deceased organ donation.
New strategies are needed to encourage organ donation. Altruism, the impulse that underlies our present system, is undermined by proposals that provide tangible inducements to improve donation which are, in their own subtle ways, coercive. I propose a new strategy based on implementing an option to donate that reinforces the strong reciprocity which drives anonymous altruism.
-
Kidney international · Mar 2006
Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis.
Toll-like receptors (TLRs) are important in sepsis. Myeloid differentiation factor 88 (MyD88) is a key molecule involved in signal transduction by multiple TLRs. The objective of this study was to investigate the contribution of TLR4 and MyD88 to acute renal failure (ARF) induced by polymicrobial sepsis. ⋯ The absence of MyD88 dissociates ARF from liver injury; liver injury is MyD88-independent. There was MyD88-dependent apoptosis in the spleen, but no apoptosis in the kidney. MyD88 may be a good drug target for some, but not all, organ dysfunctions following sepsis.
-
Kidney international · Feb 2006
CommentHypertension, race, and glomeruli: more than simply a numbers game.
Incidences of hypertension and hypertension-related renal failure are considerably higher in African-Americans than in white Americans. One explanation offered for this is that African-Americans have a higher incidence of low birth weight, the latter associated with lower numbers of glomeruli. However, although studies show a clear association between hypertension and glomerular number in whites, the situation in African-Americans appears more complex.
-
Membranoproliferative glomerulonephritis (MPGN) associated with type II cryoglobulinemia is the predominant type of hepatitis C virus (HCV)-related glomerulonephritis. The blockade of the renin-angiotensin system, as well as a combined anti-HCV therapy that associates standard or pegylated alpha-interferon with ribavirin, are mandatory in all patients experiencing an HCV-related glomerulonephritis. In patients with nephrotic-range proteinuria and/or progressive renal failure, immunosuppressive therapy is necessary. ⋯ Because it is also better tolerated, it should be preferred to cyclophosphamide. During the acute phase, plasmapheresis and steroid pulses can be used. However, future prospective, controlled, and randomized studies are still required to establish evidence-based guidelines to treat HCV-related glomerulopathies.